{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:13:25Z","timestamp":1787026405050,"version":"build-2736575974"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:00:00Z","timestamp":1740096000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Previous research on the prognostic effectiveness of examined lymph nodes (ELN), lymph node ratio (LNR), and positive lymph nodes (pN) in postoperative gastric cancer (GC) has yielded inconsistent results despite their widespread use.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This study used a competing risk model (CRM) to evaluate the prognostic efficacy of these markers in patients with GC. Data from 337 patients with lymph node (LN)-positive stage II GC undergoing resection and chemotherapy between 2010 and 2015 were collected from the Surveillance, Epidemiology, and End Results database. Optimal cutoff values for ELN and LNR were determined using restricted cubic splines, and pN was divided into three groups based on the AJCC staging system. The survival analyses were conducted using Kaplan\u2013Meier curves, Cox proportional hazards analysis, cumulative incidence curves, and CRM. Subgroup analysis and interaction tests were performed to evaluate the correlation between LN status and survival within subgroups.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The results indicated that the optimal cutoff values for ELN, LNR, and pN were 16, 0.1, and 2. Multivariate Cox analysis showed that ELN (hazard ratio [HR] = 0.67), LNR (HR = 2.23), and pN (HR = 2.80) were independent predictors of overall survival, whereas only LNR (HR = 2.08) was independently associated with disease-specific survival. The CRM revealed that LNR (sub-distribution hazard ratio [SHR] = 1.89) and pN (SHR = 2.80) were independently associated with disease-specific survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In conclusion, ELN, LNR, and pN are all significant predictors of overall survival for GC. However, LNR demonstrates stronger robustness in predicting DSS than ELN and pN. The LNR may supplement the TNM staging system in identifying prognostic discrepancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2025.1434999","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:26:09Z","timestamp":1740097569000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Prognostic performance of examined lymph nodes, lymph node ratio, and positive lymph nodes in gastric cancer: a competing risk model study"],"prefix":"10.3389","volume":"16","author":[{"given":"Xiao","family":"Gu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqi","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,2,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19124109","article-title":"Types of gastric carcinomas","volume":"19","author":"Waldum","year":"2018","journal-title":"Int J Mol Sci"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.36.5908","article-title":"Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer","volume":"29","author":"Sasako","year":"2011","journal-title":"J Clin Oncol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1097\/COC.0b013e31820dbf08","article-title":"Adjuvant radiation therapy increases overall survival in node-positive gastric cancer patients with aggressive surgical resection and lymph node dissection: a SEER database analysis","volume":"35","author":"Shridhar","year":"2012","journal-title":"Am J Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/his.12167","article-title":"Improving the standard of lymph node retrieval after gastric cancer surgery","volume":"63","author":"Hanna","year":"2013","journal-title":"Histopathology"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2024.05.031","article-title":"Revolutionizing T3-4N0-2M0 gastric cancer staging with an innovative pathologic N classification system","volume":"28","author":"Yin","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5494-7","article-title":"Influence of total lymph node count on staging and survival after gastrectomy for gastric cancer: an analysis from a two-institution database in China","volume":"24","author":"Lu","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.6004\/jnccn.2021.7038","article-title":"Navigating nodal metrics for node-positive gastric cancer in the United States: an NCDB-based study and validation of AJCC guidelines","volume":"19","author":"Erstad","year":"2021","journal-title":"J Natl Compr Canc Netw"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000002772","article-title":"Minimally invasive lobectomy is associated with lower noncancer-specific mortality in elderly patients: A propensity score matched competing risks analysis","volume":"270","author":"Hristov","year":"2019","journal-title":"Ann Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1186\/s12885-021-08683-x","article-title":"Causes of death and effect of non-cancer-specific death on rates of overall survival in adult classic Hodgkin lymphoma: a populated-based competing risk analysis","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.2217\/fon-2019-0178","article-title":"Impact of nonappendiceal cancer-specific death on overall survival: a competing risk analysis","volume":"15","author":"Wu","year":"2019","journal-title":"Future Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30617","article-title":"Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer","volume":"123","author":"Fu","year":"2017","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-08616-1","article-title":"Association between lymph node ratio and survival in patients with pathological stage II\/III gastric cancer","volume":"27","author":"Kano","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa010187","article-title":"Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction","volume":"345","author":"Macdonald","year":"2001","journal-title":"N Engl J Med"},{"key":"B15","unstructured":"National Cancer Institute, Surveillance, Epidemiology, and End Results Program\n          \n          2022"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s13304-021-01083-7","article-title":"A nomogram to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer","volume":"73","author":"Tonello","year":"2021","journal-title":"Updates Surg"},{"key":"B17","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jss.2008.12.019","article-title":"The prognostic analysis of lymph node-positive gastric cancer patients following curative resection","volume":"161","author":"Deng","year":"2010","journal-title":"J Surg Res"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.240","article-title":"Postoperative nomogram for disease-specific survival after an R0 resection for gastric carcinoma","volume":"21","author":"Kattan","year":"2003","journal-title":"J Clin Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3109\/0284186X.2012.754991","article-title":"The lymph node ratio as a prognostic factor for gastric cancer","volume":"52","author":"Nelen","year":"2013","journal-title":"Acta Oncol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2147\/DDDT.S88743","article-title":"A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy","volume":"10","author":"Qian","year":"2016","journal-title":"Drug Des Devel Ther"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1002\/bjs.6653","article-title":"Ratio of metastatic to resected lymph nodes for prediction of survival in patients with inadequately staged gastric cancer","volume":"96","author":"Kulig","year":"2009","journal-title":"Br J Surg"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/ajco.13358","article-title":"The assessment of the optimal number of examined lymph nodes and prognostic models based on lymph nodes for predicting survival outcome in patients with stage N3b gastric cancer","volume":"17","author":"Guo","year":"2021","journal-title":"Asia Pac J Clin Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2020.539030","article-title":"Importance of examined lymph node number in accurate staging and enhanced survival in resected gastric adenocarcinoma-the more, the better? A cohort study of 8,696 cases from the US and China, 2010-2016","volume":"10","author":"Huang","year":"2020","journal-title":"Front Oncol"},{"key":"B24","volume-title":"NCCN Clinical Practice Guidelines in Gastric Cancer. Version 2 ed","author":"Ajani","year":"2018"},{"key":"B25","volume-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-013-2380-5","article-title":"Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience","volume":"17","author":"Wong","year":"2013","journal-title":"J Gastrointest Surg"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181887516","article-title":"The impact of comorbidity on surgical outcomes in laparoscopy-assisted distal gastrectomy: a retrospective analysis of multicenter results","volume":"248","author":"Kim","year":"2008","journal-title":"Ann Surg"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2015.03.001","article-title":"Metastatic lymph node ratio successfully predicts prognosis in western gastric cancer patients","volume":"24","author":"Kutlu","year":"2015","journal-title":"Surg Oncol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.ijsu.2018.08.002","article-title":"Integrated analysis of the prognostic role of the lymph node ratio in node-positive gastric cancer: A meta-analysis","volume":"57","author":"Zhu","year":"2018","journal-title":"Int J Surg"},{"key":"B30","doi-asserted-by":"publisher","first-page":"994","DOI":"10.21873\/invivo.12792","article-title":"Clinical influence of the lymph node ratio on lymph node metastasis-positive gastric cancer patients who receive curative treatment","volume":"36","author":"Aoyama","year":"2022","journal-title":"In Vivo"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.4240\/wjgs.v16.i6.1660","article-title":"Tumor recurrence and survival prognosis in patients with advanced gastric cancer after radical resection with radiotherapy and chemotherapy","volume":"16","author":"Nie","year":"2024","journal-title":"World J Gastrointest Surg"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-020-05739-0","article-title":"Accurate risk stratification of patients with node-positive gastric cancer by lymph node ratio","volume":"44","author":"Nakamura","year":"2020","journal-title":"World J Surg"},{"key":"B33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s10120-013-0253-y","article-title":"Lymph node ratio is a critical prognostic predictor in gastric cancer treated with S-1 chemotherapy","volume":"17","author":"Ema","year":"2014","journal-title":"Gastric Cancer"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2017.03.013","article-title":"Lymph node ratio as a prognostic factor in gastric cancer patients following D1 resection. Comparison with the current TNM staging system","volume":"43","author":"Bouliaris","year":"2017","journal-title":"Eur J Surg Oncol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.asjsur.2017.10.001","article-title":"A prognostic model based on lymph node metastatic ratio for predicting survival outcome in gastric cancer patients with N3b subclassification","volume":"42","author":"Hung","year":"2019","journal-title":"Asian J Surg"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2015.03.225","article-title":"Prognostic value of metastatic lymph node ratio as an additional tool to the TNM stage system in gastric cancer","volume":"41","author":"Wu","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.24989","article-title":"Log odds of positive lymph nodes: a novel prognostic indicator superior to the number-based and the ratio-based N category for gastric cancer patients with R0 resection","volume":"116","author":"Sun","year":"2010","journal-title":"Cancer"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001040","article-title":"Prognostic performance of different lymph node staging systems after curative intent resection for gastric adenocarcinoma","volume":"262","author":"Spolverato","year":"2015","journal-title":"Ann Surg"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fsurg.2024.1376702","article-title":"Comparison of the predictive performance of three lymph node staging systems for late-onset gastric cancer patients after surgery","volume":"11","author":"Chen","year":"2024","journal-title":"Front Surg"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-153","article-title":"Combined features based on MT1-MMP expression, CD11b + immunocytes density and LNR predict clinical outcomes of gastric cancer","volume":"11","author":"Peng","year":"2013","journal-title":"J Transl Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-013-3082-7","article-title":"Updates on surgical management of advanced gastric cancer: new evidence and trends. Insights from the First International Course on Upper Gastrointestinal Surgery\u2013Varese (Italy), December 2, 2011","volume":"20","author":"Rausei","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1007\/s10120-012-0190-1","article-title":"The evaluation of metastatic lymph node ratio staging system in gastric cancer","volume":"16","author":"Zhou","year":"2013","journal-title":"Gastric Cancer"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.4103\/njcp.njcp_345_20","article-title":"Prognostic significance of the metastatic lymph node ratio compared to the TNM classification in stage III gastric cancer","volume":"24","author":"Gulmez","year":"2021","journal-title":"Niger J Clin Pract"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-021-10768-7","article-title":"Development of a prognostic nomogram and nomogram software application tool to predict overall survival and disease-free survival after curative-intent gastrectomy for gastric cancer","volume":"29","author":"Spolverato","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-020-09433-2","article-title":"Evaluation of lymph node staging systems as independent prognosticators in remnant gastric cancer patients with an insufficient number of harvested lymph nodes","volume":"28","author":"Kano","year":"2021","journal-title":"Ann Surg Oncol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-019-08098-w","article-title":"Modified gastric cancer AJCC staging with a classification based on the ratio of regional lymph node involvement: A population-based cohort study","volume":"27","author":"Huang","year":"2020","journal-title":"Ann Surg Oncol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ejso.2010.11.002","article-title":"The interaction between N-category and N-ratio as a new tool to improve lymph node metastasis staging in gastric cancer: results of a single cancer center in Brazil","volume":"37","author":"Coimbra","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2016.03.001","article-title":"Lymph node ratio as a novel and simple prognostic factor in advanced gastric cancer","volume":"42","author":"Yamashita","year":"2016","journal-title":"Eur J Surg Oncol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.issn.0254-6450.2017.08.026","article-title":"A new perspective of survival data on clinical epidemiology: introduction of competitive risk model","volume":"38","author":"Nie","year":"2017","journal-title":"Chin J Epidemiol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1434999\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T00:26:27Z","timestamp":1740097587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1434999\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,21]]},"references-count":49,"alternative-id":["10.3389\/fendo.2025.1434999"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1434999","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,21]]},"article-number":"1434999"}}